Ando, K., et al. (2014) Anti-Albuminuric Effect of the Aldosterone Blocker Eplerenone in Non-Diabetic Hypertensive Patients with Albuminuria: A Double-Blind, Randomised, Placebocontrolled Trial. The Lancet Diabetes and Endocrinology, 2, 944-953.
https://doi.org/10.1016/S2213-8587(14)70194-9

has been cited by the following article:

• TITLE: Complexity and Management of Chronic Kidney Disease

  AUTHORS: Pranali M. Wandile

  KEYWORDS: Chronic Kidney Disease, Stages of Chronic Kidney Disease, Diagnosis of Chronic Kidney Disease, Chronic Kidney Disease Management, Physiology of Kidneys, Pathophysiology of Kidneys, Renal Replacement Therapy

  JOURNAL NAME: Open Journal of Nephrology, Vol.13 No.3, September 21, 2023

  ABSTRACT: Chronic Kidney Disease (CKD) is ongoing damage of the kidneys, which affects their ability to filter the blood the way they should. Worldwide CKD is considered as the 16th leading cause of death and affects 8% - 16% of the population. CKD often goes unnoticed and is revealed as an incidental finding. Healthcare providers diagnose the condition as CKD based on persistent abnormal kidney function tests revealing kidney damage markers > 3 months, urine albumin creatinine ratio (UACR) > or equal to 30 mg/g per 24 hours, and GFR 2. In this article, we have discussed chronic kidney disease in terms of kidney physiology, chronic kidney disease pathophysiology, etiology, diagnosis, signs and symptoms, and management.